DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases

Clinical trial NCT00955617 · COMPLETED

Trial details

NCT number: NCT00955617
Sponsor: Guerbet
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Peripheral Arterial Disease

Start date: 2009-07-01
Primary completion: 2010-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.